SEX-DIFFERENCES IN COAGULATION AND FIBRINOLYSIS IN SUBJECTS WITH CORONARY-ARTERY DISEASE

Citation
N. Osseigerning et al., SEX-DIFFERENCES IN COAGULATION AND FIBRINOLYSIS IN SUBJECTS WITH CORONARY-ARTERY DISEASE, Thrombosis and haemostasis, 79(4), 1998, pp. 736-740
Citations number
30
Categorie Soggetti
Hematology,"Peripheal Vascular Diseas
Journal title
ISSN journal
03406245
Volume
79
Issue
4
Year of publication
1998
Pages
736 - 740
Database
ISI
SICI code
0340-6245(1998)79:4<736:SICAFI>2.0.ZU;2-1
Abstract
Women with coronary artery disease (CAD) have a prognosis at least as bad and possibly worse than men. Differences in classical risk factors do not fully account for these findings and there is evidence that ci rculating: levels of haemostatic factors may predict CAD risk. In this study sex differences in haemostatic risk factors were examined in re lation to coronary stenosis. 609 (420 men, 69%) subjects admitted for coronary angiography for suspected CAD were recruited. Levels of Facto r VII:C (FVII:C), fibrinogen plasminogen activator inhibitor-1 (PAI-1) and von Willebrand factor (vWF) were estimated in 296 subjects from o ne centre. Of these, women (n = 107) had higher levels of FVII:C (134% vs 117%, p < 0.0005), and fibrinogen (3.4 g/l vs 3.2 g/l p = 0.01) th an men (n = 189) and these differences remained after adjusting for ot her covariates. In subjects with angiographically significant atheroma these differences in haemostatic factors (n = 50 for women vs n = 147 for men) were exaggerated, (FVII:C 139% vs 117, p < 0.0001, fibrinoge n 3.7 g/l vs 3.3 g/l p = 0.003), PAI-1 (26.2 ng/ml vs 19.7 ng/ml, p = 0.02) with a trend towards higher levels of vWF in the women. Women wi th significant atheroma at angiography (n = 50) had higher levels of P AI-1 (25.0 ng/ml vs 13.4 ng/ml p < 0.0001) and vWF (1.25 IU/ml vs 1.06 IU/ml, p = 0.02) and a trend towards higher levels of both fibrinogen and FVII:C than women with normal or in significant coronary vessel d isease (n = 57). Elevated circulating levels of PAI-1, vWF, fibrinogen and FVII:C in women with angiographically proven CAD may contribute t o an adverse cardiovascular risk factor profile and the poorer prognos is in females than male patients with proven coronary artery disease.